The submission provides longer-term follow-up data, which found that Paxlovid treatment reduced the risk of hospitalization or death by 88% in non-hospitalized, high-risk adults treated within 5 days of the start of symptoms. On Thursday, Pfizer announced the submission of a new drug application to the FDA for approval of Paxlovid for patients who are at high risk for severe COVID-19, hospitalization, or death. The study failed to show that the drug reduced symptoms, hospitalizations, or deaths in a statistically significant way, Bloomberg reported. After taking Paxlovid, he was “surprised and disappointed” to see he tested positive again, and he had symptoms such as a low fever, achiness, runny nose, and “mild cough.” He then called his doctor, who prescribed another 5-day course of Paxlovid, which Fauci said is relatively common among those who have a rebound.Įarlier this month, Pfizer, the maker of Paxlovid, announced that it would stop adding new people to a clinical trial of the drug among COVID-19 patients who have a low risk of hospitalization and death.
He missed his daughter’s wedding in mid-June when he had the first infection but took part remotely, the Times reported.įauci first tested positive after having a “scratchy throat,” he told the newspaper. During the segment, he shared his own experience with contracting COVID-19. The Global Health Forum, which Fauci attended virtually, featured public health experts from across the world to talk about COVID-19, vaccines, post-pandemic priorities to strengthen health systems, the health care workforce, the HIV and AIDS pandemic, cancer care, antibiotic and antimicrobial resistance, equitable health care, and preparation for the next health emergency.įauci, director of the National Institute of Allery and Infectious Diseases, spoke in a session about stronger global health security. He has been fully vaccinated and received two boosters. įauci, 81, was prescribed Paxlovid due to his age, which puts him at greater risk for severe COVID-19 outcomes, according to Bloomberg News. “Paxlovid did what it was supposed to do,” he told The New York Times. He later said that Paxlovid kept him out of the hospital and stopped his infection from becoming more severe when he first tested positive on June 15.
0 kommentar(er)
